Annual Drug Patent Expirations for SUMAVEL+DOSEPRO
Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are nine patents protecting this drug.
SUMAVEL DOSEPRO drug price trends.
This drug has thirty-two patent family members in nine countries.
The generic ingredient in SUMAVEL DOSEPRO is sumatriptan succinate. Additional details are available on the sumatriptan succinate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
You must log in to post a comment.